• column
  • column
    • Home
    • About Us
      • Our vision
      • Our team
      • Our founders
      • News & Resources
      • Case Studies
      • Clients
      • Advisory board
  • column
    • Our Services
      • How we work
      • Project partners
    • Preclinical Research Services
    • Clinical Trial Volunteer Opportunities
    • Clinical Trials Services
  • column
    • Contact
      • Companies
      • Volunteers
    • FOLLOW US
      • X
      • Linkedin
      • Facebook
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

by Virtus | Sep 18, 2019

Click the button below to read more about this.
Role of deficient type III interferon-lambda production in asthma exacerbations.

Role of deficient type III interferon-lambda production in asthma exacerbations.

by Virtus | Sep 18, 2019

Click the button below to read more about this.
Next Entries »

Recent Posts

  • In Vivo Respiratory Studies in Preclinical Drug Development
  • Human Rhinovirus Preclinical Models and Viral Challenge Studies in Respiratory Research
  • Preclinical Efficacy Testing in Respiratory Drug Development
  • Translational Respiratory Models in Early-Stage Drug Development
  • Cigarette Smoke Models in Preclinical COPD Research

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact